2021 annual financial data
Purple Biotech 2021 Operating cash flow margin
Purple Biotech 2021 operating cash flow margin with verified reported values.
Direct answer
Operating cash flow margin was 4,709.69%.
Operating income was -17,934,000 USD and net income was -18,384,000 USD.
Operating cash flow was -15,071,000 USD.
Get free Purple Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- -320,000 USD
- Operating income
- -17,934,000 USD
- Net income
- -18,384,000 USD
- Operating cash flow
- -15,071,000 USD